Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2016

View Archived Issues

New biomarkers in rheumatoid disease presented at ACR meeting

Arsanis' ASN-100 receives FDA fast track designation

ABC-1183, a novel GSK3/CDK9 inhibitor

EC grants orphan designation to Agilis Biotherapeutics' AGIL-AADC

AmorePacific initiates phase III trial of PAC-14028 in atopic dermatitis

Vertex initiates phase II study of VX-152 combination therapy for cystic fibrosis

A first-in-class small-molecule inhibitor of PD-L1 and TIM-3

Daiichi Sankyo's DS-8201 given FDA fast track designation

First phase Ia/b data for anti-RSPO3 antibody OMP-131R10 in advanced solid tumors

City of Hope and TGen form alliance to advance precision medicine

Axial Biotherapeutics launches with series A financing

Portage Biotech forms new ophthalmic-focused company

Kalyra Pharmaceuticals patents EGFR inhibitors

Wistar Institute discloses EBNA-1 inhibitors

GlaxoSmithKline describes RIP-1 kinase 1 inhibitors

Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors

Kainos Medicine presents Brd4 inhibitors

Aequus BioPharma synthesizes melanocortin fusion peptide for treating gout

IONIS-ANGPTL3-LRx shows potential to reduce plasma ANGPTL3 and lipids

Ferring Pharmaceuticals and Ache Laboratorios Farmaceuticos form nanotechnology collaboration

Biophytis' Sarconeos safe in SARA-PK clinical study

Aradigm reports topline results from ORBIT-3 and -4 studies of Pulmaquin

Inovio Pharmaceuticals awarded grant for MAb against Zika virus

GALACTIC-HF phase III trial of omecamtiv mecarbil begins

HDAC6 inhibitor ACY-241 given U.S. orphan status for multiple myeloma

Dosing begins in phase I/II study of Agenus' INCAGN-1949

Shire's Cinryze granted U.S. orphan status for acute antibody-mediated renal transplant rejection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...